DDW 2024
The clinical research and innovations pertaining to GI diseases from the Digestive Disease Week 2024, taking place May 18-21, 2024, in Washington, DC.
Bowel urgency affects more than a quarter of patients with ulcerative colitis and almost 10% of UC patients in remission.
People with poor sleep and high genetic risk have a significantly higher risk of developing digestive diseases.
Patients with refractory UC who are treated with JAKi and withdrawal from therapy have high rates of relapse.
A third of Black and Hispanic patients with inflammatory bowel disease have post-traumatic stress.
"Top-down" treatment is superior to "accelerated step-up" therapy in newly diagnosed Crohn disease.
AI Platforms Give Inaccurate Information on Crohn Disease, Ulcerative Colitis, and Colorectal Cancer
ChatGPT and Google's Bard are not yet a viable source of health-related information for Crohn disease, ulcerative colitis.Advertisement
Advertisement
